TDAC
Translational Development Acquisition Corp.Company Information
- Company Name
- Translational Development Acquisition Corp.
- CIK
- CIK0001926599
- Category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Ticker: Exchange
- TDAC: Nasdaq, TDACU: Nasdaq, TDACW: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 05 Real Estate & Construction
- SIC
- 6770
- SIC Description
- Blank Checks
- Ticker
- TDAC
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- —
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-03-31
- Institutional shares owned
- 15,866,121
- Shares outstanding
- 17,250,000
- Ownership
- 91.98%
Earnings Market Reaction
- Filing date
- 2026-08-14
- Price on filing date
- —
- 1-month reaction
- -0.05%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | |||||||||||||
| Cash And Cash Equivalents At Carrying Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Prepaid Expense Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 1 | ||||||
| Assets Held In Trust Noncurrent | 157 | 183 | 182 | 180 | 178 | 176 | 174 | ||||||
| Assets | 157 | 183 | 182 | 180 | 178 | 177 | 175 | ||||||
Liabilities Current | |||||||||||||
| Accounts Payable And Accrued Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accounts Payable Current | - | - | - | - | - | - | 0 | ||||||
| Other Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Notes Payable Current | 1 | 1 | 0 | 0 | - | - | - | ||||||
| Liabilities Current | 2 | 1 | 1 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 8 | 7 | 7 | 6 | 6 | 6 | 6 | ||||||
Stockholders Equity | |||||||||||||
| Retained Earnings Accumulated Deficit | -8 | -7 | -7 | -6 | -6 | -6 | -6 | ||||||
| Stockholders Equity | -8 | -7 | -7 | -6 | -6 | -6 | -6 | ||||||
| Liabilities And Stockholders Equity | 157 | 183 | 182 | 180 | 178 | 177 | 175 | ||||||
| Common Class A | 5 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Classa Ordinary Shares Subject To Redemption | 0 | 0 | 0 | 0 | -17 | 17 | 0 | ||||||
| Classa Ordinary Shares Not Subject To Redemption | 5 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Class B | -5 | 5 | 5 | 0 | 0 | 5 | 5 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Shares Outstanding | - | - | - | - | - | - | 0 | ||||||
Select a line item above to chart it.
Recent filings
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialTranslational Development Acquisition Corp. (TDAC) — SEC Financial Statements & Analysis
Translational Development Acquisition Corp. (TDAC) is a blank checks company. Translational Development Acquisition Corp. trades on Nasdaq as: TDAC, TDACU, TDACW. Translational Development Acquisition Corp. (TDAC)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14. Based on that filing, Translational Development Acquisition Corp. carries a market cap of $180.13M, a P/E ratio of 32.54x, a P/B ratio of -23.44x, an enterprise value of $181.14M, and an EV/EBITDA multiple of -137.42x. On profitability, it posts a Return on Equity (ROE) of -79.94% and a Return on Assets (ROA) of 3.30%. Per share, it reports EPS of $0.33, diluted EPS of $0.33, free cash flow per share of $-0.05, and a dividend per share of $0.00. On the balance sheet, it maintains a current ratio of 0.06x, a quick ratio of 0.05x, working capital of $-1.65M, a debt-to-equity ratio of -1.01x, a debt ratio of 0.05, free cash flow of $-849.38K (TTM), and net debt of $1.01M. Figures sourced from SEC EDGAR.
- Market Cap
- $180.13M
- P/E TTM
- 32.54x
- EPS TTM
- $0.33
- P/B TTM
- -23.44x
- ROE TTM
- -79.94%
- ROA TTM
- 3.30%
- Debt To Equity
- -1.01x
- Free Cash Flow TTM
- $-849.38K
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Translational Development Acquisition Corp. in?
Translational Development Acquisition Corp. (TDAC) operates in the Blank Checks industry.
What exchange does TDAC trade on?
Translational Development Acquisition Corp. (TDAC) trades on the Nasdaq.
When was Translational Development Acquisition Corp. (TDAC)'s most recent SEC filing?
Translational Development Acquisition Corp. (TDAC)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14.
What is TDAC's market cap?
Translational Development Acquisition Corp. (TDAC) has a market capitalization of $180.13M as of 2026-06-30.
What is TDAC's P/E ratio?
Translational Development Acquisition Corp. (TDAC)'s trailing twelve month P/E ratio is 32.54x as of 2026-06-30.
What is TDAC's EPS (earnings per share)?
Translational Development Acquisition Corp. (TDAC)'s trailing twelve month EPS is $0.33 as of 2026-06-30.
What is TDAC's ROE (return on equity)?
Translational Development Acquisition Corp. (TDAC)'s trailing twelve month Return on Equity (ROE) is -79.94% as of 2026-06-30.
What is TDAC's ROA (return on assets)?
Translational Development Acquisition Corp. (TDAC)'s trailing twelve month Return on Assets (ROA) is 3.30% as of 2026-06-30.
What is TDAC's EV/EBITDA?
Translational Development Acquisition Corp. (TDAC)'s trailing twelve month EV/EBITDA is -137.42x as of 2026-06-30.